Retrospective Analysis of the Correlation Between Imaging Features and Pathology, Prognosis in Renal Tumors
NCT ID: NCT06167863
Last Updated: 2023-12-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1000 participants
OBSERVATIONAL
2023-08-31
2023-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
WHO ISUP grading high
high-grade refer to Grades 3 and 4 tumours with an unfavourable prognosis
radiomics
extracted image features from CT or MRI
WHO ISUP grading low
low-grade refer to Grades 1 and 2 tumours with a promising prognosis
radiomics
extracted image features from CT or MRI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
radiomics
extracted image features from CT or MRI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with poor respiratory coordination, resulting in significant image artifacts;
* Lesions are cystic, without discernible regions of interest, or with multiple regions of necrosis within the lesion;
* Lesions are too small, with a diameter of less than 1cm;
* Thin-slice imaging is not available in the CT scan.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zhen Li
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhen Li
professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Li Dr
Role: PRINCIPAL_INVESTIGATOR
Tongji Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhen Li
Wuhan, Hubei, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Li S, Zhou Z, Gao M, Liao Z, He K, Qu W, Li J, Kamel IR, Chu Q, Zhang Q, Li Z. Incremental value of automatically segmented perirenal adipose tissue for pathological grading of clear cell renal cell carcinoma: a multicenter cohort study. Int J Surg. 2024 Jul 1;110(7):4221-4230. doi: 10.1097/JS9.0000000000001358.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TJ-IRB20230893
Identifier Type: -
Identifier Source: org_study_id